Scientists have created a programmable drug system that can zero in on cancer cells with unprecedented accuracy. Built from synthetic DNA, it only activates when it detects a precise combination of tumor markers, preventing damage to healthy tissue. The system can also deliver multiple drugs at once, potentially overcoming resistance. This marks a step toward medicines that behave more like smart, responsive machines inside the body.
source https://www.sciencedaily.com/releases/2026/04/260402042744.htm
'Double-edged' nature of workplace resilience examined
-
From underdog stories to comeback victories, everyone loves a tale of
perseverance. But a new study suggests that highlighting workplace
resilience can som...
1 day ago
No comments:
Post a Comment